Back to Pacer Advisors, Inc. Pacer Advisors, Inc.

GSK1

16 quarters

Position history for Pacer Advisors, Inc.Pacer Advisors, Inc.'s holdings in GLAXOSMITHKLINE PLC-SPON ADR

As of its Q2 2022 13F, Pacer Advisors held 290,909 shares of GSK1 (Glaxosmithkline), worth $12.7M. Pacer Advisors' 13F filings listed GSK1 from Q2 2020 to Q2 2022, 9 quarterly filings. GSK1 was 0.1% of Pacer Advisors' reported 13F portfolio.

Final Value

$0

Final Shares

0

Total Value Change

-$4M

Total Shares Change

-104,099

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2022-Q3
Latest
Exited
0
-100.0%
$00.0%$25.18
0
2022-Q2
Increased
290,909
+138.3%
$12.7M0.1%$36.82
45
2022-Q1
Increased
122,093
+39.7%
$5.3M0.0%$36.55
36
2021-Q4
Decreased
87,419
-7.8%
$3.9M0.0%$36.47
0
2021-Q3
Decreased
94,820
-1.3%
$3.6M0.0%$31.21
0
2021-Q2
Increased
96,082
+9.0%
$3.8M0.1%$32.12
29
2021-Q1
Decreased
88,179
-4.7%
$3.1M0.1%$28.40
0
2020-Q4
Increased
92,534
+1.4%
$3.4M0.1%$28.77
27
2020-Q3
Increased
91,226
+32.0%
$3.4M0.1%$29.05
34
2020-Q2
New
69,113
-
$2.8M0.1%$31.12
36
2020-Q1
Exited
0
-100.0%
$00.0%$28.59
0
2019-Q4
Decreased
88,387
-24.6%
$4.2M0.2%$34.96
0
2019-Q3
Increased
117,244
+4.9%
$5M0.1%$31.41
34
2019-Q2
Increased
111,744
+6.4%
$4.5M0.1%$29.11
34
2019-Q1
Increased
104,988
+0.8%
$4.4M0.1%$30.02
32
2018-Q4
First report
104,099
-
$4M0.1%$27.05
0

Other major holders of GSK1: Dodge & Cox

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used